Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Illumina, Inc.(ILMN) | 119,196 | 119,196 | 0 | $15.54M | $15.93M | 13.62% | +$383.8K |
| Harmony Biosciences Holdings, Inc.(HRMY) | 368,665 | 368,665 | 0 | $14.75M | $12.69M | 10.85% | -$2.06M |
| Oculis Holding AG(OCS) | 436,378 | 436,378 | 0 | $5.35M | $7.42M | 6.34% | +$2.07M |
| Verona Pharma PlcADS | 0 | 133,040 | +133,040 | $0 | $6.18M | 5.28% | +$6.18M |
| Zai Lab LimitedADR(ZLAB) | 235,000 | 235,000 | 0 | $5.67M | $6.15M | 5.26% | +$481.8K |
| Mirum Pharmaceuticals, Inc.(MIRM) | 106,100 | 125,330 | +19,230 | $4.14M | $5.18M | 4.43% | +$1.04M |
| Merus N V | 120,038 | 120,038 | 0 | $6.00M | $5.05M | 4.32% | -$949.5K |
| Geron Corporation(GERN) | 1,373,550 | 1,373,550 | 0 | $6.24M | $4.86M | 4.16% | -$1.37M |
| Incyte Corporation(INCY) | 74,022 | 67,022 | -7,000 | $4.89M | $4.63M | 3.96% | -$263.6K |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 0 | 664,610 | +664,610 | $0 | $4.49M | 3.84% | +$4.49M |
| Xenon Pharmaceuticals Inc.(XENE) | 106,680 | 106,680 | 0 | $4.20M | $4.18M | 3.58% | -$18.1K |
| Replimune Group, Inc.(REPL) | 287,846 | 321,746 | +33,900 | $3.15M | $3.90M | 3.33% | +$741.6K |
| Tourmaline Bio Inc | 146,800 | 187,090 | +40,290 | $3.77M | $3.79M | 3.25% | +$20.0K |
| BeOne Medicines AGADR(ONC) | 23,022 | 19,997 | -3,025 | $5.17M | $3.69M | 3.16% | -$1.48M |
| Soleno Therapeutics Inc | 63,950 | 79,650 | +15,700 | $3.23M | $3.58M | 3.06% | +$351.4K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 9,762 | 11,122 | +1,360 | $2.07M | $3.43M | 2.94% | +$1.36M |
| Standard BioTools Inc.(LAB) | 1,883,179 | 1,883,179 | 0 | $3.63M | $3.30M | 2.82% | -$339.0K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 49,120 | 49,120 | 0 | $2.57M | $2.75M | 2.35% | +$176.3K |
| Exelixis, Inc.(EXEL) | 64,200 | 64,200 | 0 | $1.67M | $2.14M | 1.83% | +$471.9K |
| Acadia Pharmaceuticals Inc | 102,984 | 102,984 | 0 | $1.58M | $1.89M | 1.62% | +$305.9K |
| Ascendis Pharma A/SADR(ASND) | 13,600 | 13,600 | 0 | $2.03M | $1.87M | 1.60% | -$158.3K |
| Rubrik, Inc.CL A(RBRK) | 0 | 24,338 | +24,338 | $0 | $1.59M | 1.36% | +$1.59M |
| Kalvista Pharmaceuticals Inc | 154,522 | 154,522 | 0 | $1.79M | $1.31M | 1.12% | -$480.6K |
| Kymera Therapeutics, Inc.(KYMR) | 10,875 | 30,875 | +20,000 | $514.7K | $1.24M | 1.06% | +$727.4K |
| Bicycle Therapeutics PlcADS | 31,585 | 68,943 | +37,358 | $714.8K | $965.2K | 0.83% | +$250.4K |
| Entrada Therapeutics, Inc.(TRDA) | 49,082 | 49,082 | 0 | $784.3K | $848.6K | 0.73% | +$64.3K |
| Revolution Medicines, Inc.(RVMD) | 7,300 | 19,253 | +11,953 | $331.1K | $842.1K | 0.72% | +$511.1K |
| Climb Bio, Inc.(CLYM) | 463,654 | 463,654 | 0 | $2.36M | $834.6K | 0.71% | -$1.53M |
| Rani Therapeutics Holdings, Inc.CL A(RANI) | 493,584 | 493,584 | 0 | $1.07M | $676.2K | 0.58% | -$389.9K |
| Bolt Biotherapeutics Inc | 1,166,952 | 1,166,952 | 0 | $756.2K | $624.4K | 0.53% | -$131.7K |
| Bolt Projs Hldgs Inc | 811,952 | 811,952 | 0 | $665.8K | $391.4K | 0.33% | -$274.4K |
| argenx SEADR(ARGX) | 430 | 430 | 0 | $233.1K | $264.4K | 0.23% | +$31.4K |
| DBV Technologies S.A.ADS(DBVT) | 0 | 37,095 | +37,095 | $0 | $114.6K | 0.10% | +$114.6K |
| ALX Oncology Holdings Inc.(ALXO) | 41,950 | 41,950 | 0 | $76.3K | $70.1K | 0.06% | -$6.3K |
| Affimed N V | 37,247 | 37,247 | 0 | $125.2K | $44.3K | 0.04% | -$80.8K |
| Aerovate Therapeutics Inc | 47,936 | 0 | -47,936 | $100.2K | $0 | — | -$100.2K |
| BioMarin Pharmaceutical Inc.(BMRN) | 10,815 | 0 | -10,815 | $760.2K | $0 | — | -$760.2K |
| Dbv Technologies S AADR | 185,475 | 0 | -185,475 | $129.8K | $0 | — | -$129.8K |
| Exscientia PlcADS | 859,892 | 0 | -859,892 | $4.20M | $0 | — | -$4.20M |
| Longboard Pharmaceuticals In | 160,570 | 0 | -160,570 | $5.35M | $0 | — | -$5.35M |
| Springworks Therapeutics Inc | 7,450 | 0 | -7,450 | $238.7K | $0 | — | -$238.7K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 3,820 | 0 | -3,820 | $212.2K | $0 | — | -$212.2K |